Sign In

Login

Password

Forgot Password ? Sign Up

נוסינרסן (Hebrew Wikipedia)

Analysis of information sources in references of the Wikipedia article "נוסינרסן" in Hebrew language version.

refsWebsite
Global rank Hebrew rank
3nih.gov
4th place
18th place
1springer.com
274th place
120th place
1who.int
195th place
160th place
1degruyter.com
1,425th place
510th place
1fda.gov
447th place
285th place
1sciencemag.org
857th place
207th place
1the-scientist.com
7,827th place
4,796th place
1cshl.edu
low place
6,256th place
1genengnews.com
low place
low place
1reuters.com
49th place
105th place
1treatsma.uk
low place
low place

cshl.edu

degruyter.com

fda.gov

accessdata.fda.gov

genengnews.com

nih.gov

ncbi.nlm.nih.gov

  • Eric W. Ottesen ISS-N1 makes the first FDA-approved drug for spinal muscular atrophy, Translational Neuroscience. 8 (1): 1–6. doi:10.1515/tnsci-2017-0001. ISSN 2081-6936. PMC 5382937. PMID 28400976.
  • Zanetta, C; Nizzardo, M; Simone, C; Monguzzi, E; Bresolin, N; Comi, GP; Corti, S (1 January 2014). "Molecular Therapeutic Strategies for Spinal Muscular Atrophies: Current and Future Clinical Trials". Clinical Therapeutics. 36 (1): 128–40. doi:10.1016/j.clinthera.2013.11.006. PMID 24360800.
  • Garber, K (11 October 2016). "Big win possible for Ionis/Biogen antisense drug in muscular atrophy". Nature Biotechnology. 34(10): 1002–1003. doi:10.1038/nbt1016-1002. PMID 27727217.

reuters.com

sciencemag.org

springer.com

adisinsight.springer.com

the-scientist.com

treatsma.uk

who.int